SCHEMBL29601352

SCHEMBL29601352

CCOC(=O)CNC(=O)c1ccc(OC)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.57
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
ALDH1A1 P00352 6/20 0.48
HPGD P15428 4/20 0.48
POLB P06746 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CFTR P13569 1/20 0.45
EGLN1 Q9GZT9 1/20 0.45
RXFP1 Q9HBX9 1/20 0.44
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TSHR P16473 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27039815 1.00 SMN1; SMN2 (0.57) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL12923841 0.89 KDM4E (0.53) RAB9AALDH1A1HPGDPOLBCYP1A2
SCHEMBL31086435 0.84 MAPT (0.53) RAB9AALDH1A1HPGDPOLBCYP1A2
SCHEMBL31086536 0.84 ALDH1A1 (0.44) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL29601724 0.83 EGLN1 (0.59) SMN1; SMN2RAB9AALDH1A1HPGDPOLB
SCHEMBL12924130 0.83 EGLN1 (0.59) SMN1; SMN2RAB9AALDH1A1HPGDPOLB
SCHEMBL12925136 0.83 HPGDS (0.53) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL12924825 0.82 HPGDS (0.56) RAB9AALDH1A1HPGDPOLBCYP1A2
SCHEMBL31086414 0.81 HPGD (0.44) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL29601227 0.79 GRM5 (0.44) SMN1; SMN2RAB9ANPC1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed